Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial

The Lancet

Volumn 387, Issue 10022, 2016, Pages 945-956

  Jacobs, Ian J ^a,b,t   Menon, Usha ^a   Ryan, Andy ^a   Gentry Maharaj, Aleksandra ^a   Burnell, Matthew ^a   Kalsi, Jatinderpal K ^a   Amso, Nazar N ^c   Apostolidou, Sophia ^a   Benjamin, Elizabeth ^a   Cruickshank, Derek ^d   Crump, Danielle N ^a   Davies, Susan K ^a   Dawnay, Anne ^a   Dobbs, Stephen ^e   Fletcher, Gwendolen ^a   Ford, Jeremy ^a,f   Godfrey, Keith ^g   Gunu, Richard ^a   Habib, Mariam ^a,h   Hallett, Rachel ^a,i   Herod, Jonathan ^j,k   Jenkins, Howard ^l   Karpinskyj, Chloe ^a   Leeson, Simon ^m   Lewis, Sara J ^a   Liston, William R ^a   Lopes, Alberto ^g,n   Mould, Tim ^a,o   Murdoch, John ^p   Oram, David ^q   Rabideau, Dustin J ^r   Reynolds, Karina ^q   Scott, Ian ^l   Seif, Mourad W ^s,t   Sharma, Aarti ^a,u   Singh, Naveena ^v   Taylor, Julie ^a   Warburton, Fiona ^a,w   Widschwendter, Martin ^a   Williamson, Karin ^x   Woolas, Robert ^a,y   Fallowfield, Lesley ^z   McGuire, Alistair J ^aa   Campbell, Stuart ^ab   Parmar, Mahesh ^a   Skates, Steven J ^r,ac   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^e BELFAST CITY HOSPITAL   (United Kingdom)

^f Qatari Shareholding Company   (Qatar)

^g QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^h NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

ⁱ BANGOR UNIVERSITY   (United Kingdom)

^j LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^k HAMAD MEDICAL CORPORATION   (Qatar)

^l ROYAL DERBY HOSPITAL   (United Kingdom)

^m Llandudno LL30 1LB   (United Kingdom)

ⁿ DERRIFORD HOSPITAL   (United Kingdom)

^o ROYAL FREE HOSPITAL   (United Kingdom)

^p ST MICHAEL'S HOSPITAL   (United Kingdom)

^q ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^r MASSACHUSETTS GENERAL HOSPITAL   (United States)

^s ST MARY S HOSPITAL   (United Kingdom)

^t UNIVERSITY OF MANCHESTER   (United Kingdom)

^u UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^v BARTS HEALTH NHS TRUST   (United Kingdom)

^w PUBLIC HEALTH ENGLAND   (United Kingdom)

^x NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^y QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^z UNIVERSITY OF SUSSEX   (United Kingdom)

^aa LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^ab Create Health Clinic   (United Kingdom)

^ac HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; PATIENT HISTORY OF BILATERAL OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UNITED KINGDOM; ALGORITHM; BLOOD; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODEL;

CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

AGED; ALGORITHMS; CA-125 ANTIGEN; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; UNITED KINGDOM;

EID: 84959863810     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)01224-6     Document Type: Article

References (41)

1. UK Cancer Research Ovarian cancer survival statistics. One-, five- and ten-year survival for ovarian cancer http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer/survival/#heading-Zero (accessed Nov 3, 2015)
2. I Jacobs, I Stabile, J Bridges et al. Multimodal approach to screening for ovarian cancer Lancet 1 1988 268 271
3. IJ Jacobs, S Skates, AP Davies et al. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: A prospective cohort study BMJ 313 1996 1355 1358
4. U Menon, A Talaat, AR Jeyarajah et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation Br J Cancer 80 1999 1644 1647
5. IJ Jacobs, SJ Skates, N MacDonald et al. Screening for ovarian cancer: A pilot randomised controlled trial Lancet 353 1999 1207 1210
6. SJ Skates, DK Pauler, IJ Jacobs Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers J Am Stat Assoc 96 2001 429 439
7. SJ Skates, U Menon, N MacDonald et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women J Clin Oncol 21 suppl 10 2003 206s 210s
8. U Menon, A Talaat, AN Rosenthal et al. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening BJOG 107 2000 165 169
9. U Menon, SJ Skates, S Lewis et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer J Clin Oncol 23 2005 7919 7926
10. Cancer Research UK Ovarian cancer statistics. Ovarian cancer mortality http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer#heading-One (accessed Oct 6, 2015)
11. Cancer Research UK Ovarian cancer survival statistics. Ovarian cancer survival by stage at diagnosis http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer/survival#heading-Three (accessed Oct 6, 2015)
12. U Menon, A Gentry-Maharaj, A Ryan et al. Recruitment to multicentre trials - lessons from UKCTOCS: Descriptive study BMJ 337 2008 a2079
13. U Menon, A Gentry-Maharaj, R Hallett et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 2009 327 340
14. U Menon, A Ryan, J Kalsi et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening J Clin Oncol 33 2015 2062 2071
15. J Barrett, V Jenkins, V Farewell et al. Psychological morbidity associated with ovarian cancer screening: Results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS) BJOG 121 2014 1071 1079
16. A Sharma, M Burnell, A Gentry-Maharaj et al. Quality assurance and its impact on ovarian visualisation rates in the multicentre United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Ultrasound Obstet Gynecol 2015 10.1002/uog.14929 published online June 19.
17. J Prat for the FIGO Committee on Gynecologic Oncology Staging classification for cancer of the ovary, fallopian tube, and peritoneum Int J Gynaecol Obstet 124 2014 1 5
18. FA Tavassoli, P Devilee World Health Organization Classification of Tumours. Pathology and genetics. Tumors of the breast and female genital organs 2003 World Health Organization Lyon
19. D Daya, AN Cheung, S Khunamornpong et al. Tumors of the peritoneum: Epithelial tumors of Müllerian type RJ Kurman ML Carcangiu CS Herrington RH Young WHO classification of tumors of female reproductive organs 4th edn 2014 International Agency for Research on Cancer Lyon 92 93
20. SG Self An adaptive weighted log-rank test with application to cancer prevention and screening trials Biometrics 47 1991 975 986
21. SG Self, R Etzioni A likelihood ratio test for cancer screening trials Biometrics 51 1995 44 50
22. Y Shen, J Cai Maximum of the weighted Kaplan-Meier tests with application to cancer prevention and screening trials Biometrics 57 2001 837 843
23. J Warwick, SW Duffy A review of cancer screening evaluation techniques, with some particular examples in breast cancer screening J R Stat Soc Ser A 168 2005 657 677
24. SS Buys, E Partridge, A Black et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 2011 2295 2303
25. GL Andriole, ED Crawford, RL Grubb 3rd et al. Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
26. MM Oken, WG Hocking, PA Kvale et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial JAMA 306 2011 1865 1873
27. RE Schoen, PF Pinsky, JL Weissfeld et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy N Engl J Med 366 2012 2345 2357
28. National Lung Screening Trial Research Team DR Aberle, AM Adams et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
29. TR Fleming, DP Harrington Counting processes and survival analysis 2011 John Wiley & Sons Hoboken
30. G Izmirlian Estimation of the relative risk following group sequential procedure based upon the weighted log-rank statistic Stat Interface 7 2014 27 42
31. P Royston, MK Parmar Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects Stat Med 21 2002 2175 2197
32. ZA Liu, JA Hanley, EC Strumpf Projecting the yearly mortality reductions due to a cancer screening programme J Med Screen 20 2013 157 164
33. JP Fine, RJ Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
34. Carpenter B, Gelman A, Hoffman M, et al. Stan: A probabilistic programming language. J Stat Softw (in press).
35. SW Lagakos, DA Schoenfeld Properties of proportional-hazards score tests under misspecified regression models Biometrics 40 1984 1037 1048
36. FH Schroder, J Hugosson, MJ Roobol et al. Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
37. O Holme, M Loberg, M Kalager et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: A randomized clinical trial JAMA 312 2014 606 615
38. M Loberg, ML Lousdal, M Bretthauer, M Kalager Benefits and harms of mammography screening Breast Cancer Res 17 2015 63
39. A Gentry-Maharaj, A Sharma, M Burnell et al. Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening Ultrasound Obstet Gynecol 41 2013 73 79
40. KH Lu, S Skates, MA Hernandez et al. A 2-stage ovarian cancer screening strategy using the risk of ovarian cancer algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value Cancer 119 2013 3454 3461
41. R Iyer, A Gentry-Maharaj, A Nordin et al. Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications) Br J Cancer 112 2015 475 484